Freiburg, Germany

Karsten Maeder

USPTO Granted Patents = 3 


Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 2004-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Karsten Maeder

Introduction

Karsten Maeder is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that aid in the treatment of obesity. With a total of 3 patents to his name, Maeder's work is recognized for its innovative approach to health solutions.

Latest Patents

Among his latest patents is a lipase inhibiting composition. This pharmaceutical composition contains a lipase inhibitor with a melting point of ≥37°C, along with a sucrose fatty acid ester that can be a mono-, di-, tri-, or tetra-ester. The inclusion of one or more pharmaceutically acceptable excipients enhances its utility in treating obesity. This innovative formulation showcases Maeder's commitment to addressing significant health challenges.

Career Highlights

Karsten Maeder is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at this esteemed organization has allowed him to focus on developing effective treatments that can improve the quality of life for many individuals.

Collaborations

Throughout his career, Maeder has collaborated with talented professionals, including Lukas Christoph Scheibler and Rainer Eugen Martin. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Karsten Maeder's contributions to pharmaceutical innovations, particularly in obesity treatment, highlight his role as a significant inventor in the field. His work continues to inspire advancements in health solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…